肝硬化并发自发性细菌性腹膜炎患者血清与腹水TNF-α、IL-6和IL-8水平差异比较

doi:10.3969/j.issn.1672-5069.2015.02.022

Abstract

Tong Fangfang. TNF alpha, IL-6 and IL-8 levels in sera and ascites of patients with iver cirrhosis complicated by spontaneous bacterial peritonitis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(2): 191-192.

References

[1] 刘宝华,张长青,袁翠云. 肝炎后肝硬化并发自发性腹膜炎58例临床分析. 河南大学学报（医学版）,2009,28（2）:142-144.
[2] 孙波. 肝硬化腹水并发自发性细菌性腹膜炎相关因素分析. 中国乡村医药杂志,2013,20（1）:25-26.
[3] 熊清芳,余琼华,戴列军,等. 肝硬化自发性腹膜炎患者血浆、腹水ICAM-1和趋化因子检测及其意义. 咸宁学院学报,2010,24（1）:23-26.
[4] 中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案. 传染病信息,2000,13（4）:141-150.
[5] 朱锦腾,杨春平,郑献敏,等.护肠汤对急性弥漫性腹膜炎患者血清内毒素及TNF-α、IL-6水平的影响.湖南中医杂志,2010,26（1）:14-15.
[6] 彭晟. 急性胰腺炎患者血清TNF-α水平检测的临床意义. 中外医学研究,2013,11（5）:31-32.
[7] 邵东,汪良芝.肝硬化并发自发性腹膜炎腹水细胞因子测定的临床意义. 实用临床医药杂志,2009,13（4）:84-86.
[8] 喻长法,周石桥.自发性腹膜炎患者血清、腹水中TNF-α、IL-6和IL-8的变化及其临床意义.中国卫生检验杂志,2013,23（18）:3533-3534.
[9] 梁坚,吴康英,周宇,等.肝硬化并自发性腹膜炎患者血清及腹水瘦素、肿瘤坏死因子-α、白细胞介素-6临床意义的探讨. 中西医结合肝病杂志,2009,19（5）: 278-290.
[10] 储建坤,刘荣欣,张征,等. 乳果糖联合培菲康对肝硬化自发性腹膜炎血清和腹水TNF-α、IL-6水平的影响.河北医药,2011,33（10）:1451-1452.
[11] 张莉,浦俭斌,王晓春,等.肝炎肝硬化并发自发性细菌性腹膜炎患者TNF-α和IL-6检测的临床意义. 山东医药,2011,51（8）:93-95.
[12] 梁坚,王婉梅,梁伟娟. 肝硬化患者血清瘦素与肿瘤坏死因子变化的研究. 中国医师杂志,2005,9（7）:1263-1264.
[13] 陈银芸,霍继荣. 乙型肝炎肝硬化并发腹膜炎患者血清及腹腔积液TNF-α、IL-8、IL-18水平临床意义的探讨. 中国当代医药,2010,17（14）:32-34.
[14] 武彩云.肝硬化腹水并腹膜炎ICAM-1、IL-8和PGE的临床意义.基层医学论坛,2012,16（7）:820-822.
[15] 邬明. TNF-α、IL-8、IL-18在乙型肝炎肝硬化并发自发腹膜炎患者血清及腹腔液中表达变化及临床意义探讨.医学信息,2011,24（7）:73-74.

TNF alpha, IL-6 and IL-8 levels in sera and ascites of patients with iver cirrhosis complicated by spontaneous bacterial peritonitis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[3]	Zhu Yage, Liu Jinfeng.. Therapeutic efficacy of adenosine methionine and glycyrrhizin combination in treatment of patients with alcoholic cirrhosis and its effect on serum BGP levels [J]. Journal of Practical Hepatology, 2019, 22(6): 872-875.
[4]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[5]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[6]	Liu Li, Yang Lie, Chen Haiyang, et al.. Changes of hemodynamics after splenectomy combined with pericardial devascularization in patients with cirrhotic portal hypertention complicated by splenic artery steal syndrome [J]. Journal of Practical Hepatology, 2019, 22(6): 884-887.
[7]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[8]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[9]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[10]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[11]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[12]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[13]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.
[14]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[15]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.